Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe SepsisEdward Abraham, Abla A. Creasey, Konrad Reinhart et al.|JAMA|2003Cited by 958
Research design considerations for chronic pain prevention clinical trialsJennifer S. Gewandter, Gary A. Walco, John D. Markman et al.|Pain|2015Cited by 143
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendationsJennifer S. Gewandter, Richard E. White, Robert H. Dworkin et al.|Pain|2014Cited by 110